Published in Antimicrob Agents Chemother on September 01, 1991
Effects of an acidic beverage (Coca-Cola) on absorption of ketoconazole. Antimicrob Agents Chemother (1995) 1.04
In vivo interaction of ketoconazole and sucralfate in healthy volunteers. Antimicrob Agents Chemother (1994) 0.88
Didanosine reduces atevirdine absorption in subjects with human immunodeficiency virus infections. Antimicrob Agents Chemother (1996) 0.79
In vitro analysis of the interaction between sucralfate and ketoconazole. Antimicrob Agents Chemother (1994) 0.77
Azole interactions with multidrug therapy in pediatric oncology. Eur J Clin Pharmacol (2012) 0.76
Sulfur Containing Scaffolds in Drugs: Synthesis and Application in Medicinal Chemistry. Curr Top Med Chem (2016) 0.76
Systemic antifungal drugs: Are we making any progress? Can J Infect Dis (1994) 0.75
The compromised host and infection. II. Deep fungal infection. J Infect Dis (1969) 4.63
Development and characteristics of sucralfate. J Clin Gastroenterol (1981) 1.76
Sucralfate reduces the gastrointestinal absorption of norfloxacin. Antimicrob Agents Chemother (1989) 1.74
The influence of gastric acidity on the bio-availability of ketoconazole. J Antimicrob Chemother (1980) 1.68
Opportunistic fungal infections in patients with neoplastic disease. Am J Med (1984) 1.66
In vitro and in vivo evaluation of antifungal agents. Eur J Clin Microbiol Infect Dis (1989) 1.52
Evaluation of the pH-sensitive telemetering capsule in the estimation of gastric secretory capacity. Am J Dig Dis (1966) 1.13
Amphotericin B or ketoconazole therapy of fungal infections in neutropenic cancer patients. Antimicrob Agents Chemother (1987) 1.08
Lack of effect of sucralfate on prednisone bioavailability. Am J Gastroenterol (1987) 0.92
Heidelberg capsule. I. In vitro evaluation of a new instrument for measuring intragastric pH. J Pharm Sci (1965) 0.88
Efficacy of oral sucralfate suspension in prevention and treatment of chemotherapy-induced mucositis. J Pediatr (1988) 0.85
Evaluation of the Heidelberg pH capsule. Method of tubeless gastric analysis. Am J Surg (1969) 0.84
Determination of ketoconazole in the plasma, liver, lung and adrenal of the rat by high-performance liquid chromatography. J Chromatogr (1986) 0.83
Effect of sucralfate on phenytoin bioavailability. Drug Intell Clin Pharm (1986) 0.83
Effects of concurrent sucralfate administration on pharmacokinetics of naproxen. Am J Med (1987) 0.81
Sucralfate suspension for stomatitis. Drug Intell Clin Pharm (1984) 0.81
In vitro and In vivo evaluations of a tableted antacid and sucralfate, a new antiulcer agent. Am J Gastroenterol (1981) 0.79
Effect of concurrent sucralfate administration on the absorption of erythromycin. J Clin Pharmacol (1990) 0.79
Cigarette smoking in pregnancy: its influence on birth weight and perinatal mortality. Br Med J (1972) 7.69
Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrob Agents Chemother (1993) 7.05
Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science (1991) 6.12
Standards for children's height at ages 2-9 years allowing for heights of parents. Arch Dis Child (1970) 5.85
A new system of dental age assessment. Hum Biol (1973) 5.13
Smoking in pregnancy and subsequent child development. Br Med J (1973) 4.00
Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group. Antimicrob Agents Chemother (1994) 3.73
Factors influencing the height of seven year old children--results from the National Child Development Study. Hum Biol (1971) 3.04
Pharmacokinetic and clinical studies in patients with cimetidine-associated mental confusion. Lancet (1979) 2.71
The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents. Clin Pharmacokinet (1995) 2.66
Evaluation of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections. Impact of plasma concentrations, organism, minimum inhibitory concentration, and clinical condition on bacterial eradication. Arch Intern Med (1989) 2.56
Visual acuity and field of vision of urban and rural Egyptians. Public Health Rep (1969) 2.51
Three strategies for changing attributions about severe mental illness. Schizophr Bull (2001) 2.39
Role for dual individualization with cefmenoxime. Am J Med (1984) 2.29
Pharmacokinetics and safety of trovafloxacin (CP-99,219), a new quinolone antibiotic, following administration of single oral doses to healthy male volunteers. J Antimicrob Chemother (1995) 2.29
Noncompartmental determination of the steady-state volume of distribution during multiple dosing. J Pharm Sci (1984) 2.20
Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy. Antimicrob Agents Chemother (1998) 2.19
Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin. Clin Pharmacol Ther (1989) 2.08
A multilevel model framework for meta-analysis of clinical trials with binary outcomes. Stat Med (2000) 2.06
A study of services and needs of teenage pregnant girls in the large cities of the United States. Am J Public Health (1973) 1.97
Acquired myopia in 11-year-old children. Br Med J (1977) 1.97
The 1972 Cuban national child growth study as an example of population health monitoring: design and methods. Ann Hum Biol (1975) 1.94
Gentamicin disposition and tissue accumulation on multiple dosing. J Pharmacokinet Biopharm (1977) 1.90
Multilevel modelling of the geographical distributions of diseases. J R Stat Soc Ser C Appl Stat (1999) 1.89
Development of a population pharmacokinetic model and optimal sampling strategies for intravenous ciprofloxacin. Antimicrob Agents Chemother (1993) 1.88
Problems faced in conducting a blindness survey in a developing country. East Afr Med J (1970) 1.85
In vitro selection of resistant Helicobacter pylori. Antimicrob Agents Chemother (1990) 1.83
Tissue persistence of gentamicin in man. JAMA (1977) 1.79
Social stories, written text cues, and video feedback: effects on social communication of children with autism. J Appl Behav Anal (2001) 1.74
Sucralfate reduces the gastrointestinal absorption of norfloxacin. Antimicrob Agents Chemother (1989) 1.74
Mice transgenic for human CD4 and CCR5 are susceptible to HIV infection. Proc Natl Acad Sci U S A (1997) 1.74
Antimicrobial activity of quinupristin-dalfopristin (RP 59500, Synercid) tested against over 28,000 recent clinical isolates from 200 medical centers in the United States and Canada. Diagn Microbiol Infect Dis (1998) 1.71
Height, weight, and the assessment of obesity in children. Br J Prev Soc Med (1972) 1.71
The "at risk" register: a statistical evaluation. Br J Prev Soc Med (1970) 1.71
Enhancement of HIV-1 infection by the capsular polysaccharide of Cryptococcus neoformans. Lancet (1992) 1.67
Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functionalnature of renal failure in advanced liver disease. N Engl J Med (1969) 1.64
Possible teratogenic effect of cigarette smoking. Nature (1971) 1.63
Inhibition of enoxacin absorption by antacids or ranitidine. Antimicrob Agents Chemother (1989) 1.59
Faculty advisor program for family medicine residents. Can Fam Physician (1997) 1.59
Enhanced biotransformation of theophylline in marihuana and tobacco smokers. Clin Pharmacol Ther (1978) 1.59
Definition of perinatal mortality. Lancet (1977) 1.57
Factors affecting theophylline clearances: age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol. J Pharm Sci (1979) 1.56
Benchmark analysis of strategies hospitals use to control antimicrobial expenditures. Am J Health Syst Pharm (1996) 1.53
Antibiotic tissue penetration and its relevance: models of tissue penetration and their meaning. Antimicrob Agents Chemother (1991) 1.52
Liquid-chromatographic determination of ciprofloxacin in serum and urine. Clin Chem (1985) 1.52
Accumulation pharmacokinetics of tobramycin. Antimicrob Agents Chemother (1978) 1.51
Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection response. Antimicrob Agents Chemother (1991) 1.50
Prevalence and causes of blindness in urban and rural areas of Egypt. Public Health Rep (1970) 1.50
Gentamicin tissue accumulation and nephrotoxic reactions. JAMA (1978) 1.49
Renal clearance and tissue accumulation of gentamicin. Clin Pharmacol Ther (1977) 1.48
Growth of radiologically determined heart diameter, lung width, and lung length from 5-19 years, with standards for clinical use. Arch Dis Child (1972) 1.47
Pulmonary vasculitis--an uncommon complication of ulcerative colitis. Report of a case. N Engl J Med (1968) 1.44
Comparison of two methods for determining in vitro postantibiotic effects of three antibiotics on Escherichia coli. Antimicrob Agents Chemother (1988) 1.44
Trends in antibiotic utilization and bacterial resistance. Report of the National Nosocomial Resistance Surveillance Group. Diagn Microbiol Infect Dis (1992) 1.43
Vancomycin treatment failures in Staphylococcus aureus lower respiratory tract infections. Int J Antimicrob Agents (2000) 1.43
The reported demography and causes of blindness throughout the world. Adv Ophthalmol (1980) 1.42
Pharmacokinetics and pharmacodynamics of oral grepafloxacin in patients with acute bacterial exacerbations of chronic bronchitis. J Antimicrob Chemother (1997) 1.42
Alteration of theophylline clearance and half-life by cimetidine in normal volunteers. Ann Intern Med (1981) 1.41
Influence of fluoroquinolone purchasing patterns on antimicrobial expenditures and Pseudomonas aeruginosa susceptibility. Am J Health Syst Pharm (1999) 1.41
New systems for dental maturity based on seven and four teeth. Ann Hum Biol (1976) 1.41
Increased gastric pH and the bioavailability of fluconazole and ketoconazole. Ann Intern Med (1991) 1.40
Inhibition of norfloxacin absorption by antacids. Antimicrob Agents Chemother (1990) 1.38
Comparison of responses to SF-36 Health Survey questions with one-week and four-week recall periods. Health Serv Res (1997) 1.38
Visual acuity as related to causes of blindness, age and sex in urban and rural Egyptians. Am J Public Health (1971) 1.36
The responsiveness of disease-specific and generic health measures to changes in the severity of asthma among adults. Qual Life Res (1998) 1.35
Blindness prevalence rates in Egypt. HSMHA Health Rep (1972) 1.33
Effect of multiple dose oral ciprofloxacin on the pharmacokinetics of theophylline and indocyanine green. J Antimicrob Chemother (1987) 1.33
Pharmacokinetic and pharmacodynamic activities of ciprofloxacin against strains of Streptococcus pneumoniae, Staphylococcus aureus, and Pseudomonas aeruginosa for which MICs are similar. Antimicrob Agents Chemother (1994) 1.30
The quinolones: an overview and comparative appraisal of their pharmacokinetics and pharmacodynamics. J Clin Pharmacol (1988) 1.28
Comparative nephrotoxicity of gentamicin and tobramycin: pharmacokinetic and clinical studies in 201 patients. Antimicrob Agents Chemother (1981) 1.27
Dose-ranging pharmacokinetic study of ciprofloxacin after 200-, 300-, and 400-mg intravenous doses. Ann Pharmacother (1992) 1.25
Ecological considerations in the creation and the use of child growth standards. Lancet (1980) 1.25
Association of perinatal factors with blindness in children. Public Health Rep (1967) 1.24
A comparison of skinfold measurements using the Best and Harpenden calipers. Hum Biol (1970) 1.23
The use of birthweight and gestation to assess perinatal mortality risk. J Epidemiol Community Health (1979) 1.23
Tonsillectomy and circumcision: comparisons of two cohorts. Int J Epidemiol (1978) 1.23
Methicillin distribution in serum and extravascular fluid and its relevance to normal and damaged heart valves. Antimicrob Agents Chemother (1981) 1.22
Disseminated human immunodeficiency virus 1 (HIV-1) infection in SCID-hu mice after peripheral inoculation with HIV-1. J Exp Med (1994) 1.22
Urinary casts as an indicator of renal tubular damage in patients receiving aminoglycosides. Antimicrob Agents Chemother (1979) 1.21
The saline load test--a bedside evaluation of gastric retention. Gastroenterology (1965) 1.20
Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics. Am J Med (1991) 1.19
In vitro pharmacodynamics of piperacillin, piperacillin-tazobactam, and ciprofloxacin alone and in combination against Staphylococcus aureus, Klebsiella pneumoniae, Enterobacter cloacae, and Pseudomonas aeruginosa. Antimicrob Agents Chemother (1995) 1.19
Hypercalcemia and gastric secretion in man. J Appl Physiol (1966) 1.19
Evaluation of a short form for measuring health-related quality of life among pediatric asthma patients. J Allergy Clin Immunol (2000) 1.19
Animal model distinguishing in vitro from in vivo carbenicillin-aminoglycoside interactions. Antimicrob Agents Chemother (1980) 1.19
Divergent effects of chronic HIV-1 infection on human thymocyte maturation in SCID-hu mice. J Immunol (1995) 1.18
Integration of pharmacokinetics and pharmacodynamics of methicillin in curative treatment of experimental endocarditis. J Antimicrob Chemother (1984) 1.15
Demonstration that human B cells respond differently to interleukin 2 and B cell differentiation factor based on their stages of maturation. J Immunol (1986) 1.15
Linezolid in the treatment of osteomyelitis: results of compassionate use experience. Infection (2004) 1.13
Relationship of gentamicin serum concentrations to gestational age in preterm and term neonates. J Pediatr (1980) 1.13
General revenue sharing funds for the health care of mothers and children. Am J Dis Child (1977) 1.13
Survivorship and causes of death among the blind. J Chronic Dis (1966) 1.13
Efficient statistical modelling of longitudinal data. Ann Hum Biol (1986) 1.12